John H. Leaman - 21 Nov 2025 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role
Director
Signature
/s/ John Leaman
Issuer symbol
TRAW
Transactions as of
21 Nov 2025
Net transactions value
$0
Form type
4
Filing time
25 Nov 2025, 18:53:15 UTC
Previous filing
14 Oct 2025
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leaman John Harold Director C/O TRAWS PHARMA, INC., 12 PENNS TRAIL, NEWTON /s/ John Leaman 25 Nov 2025 0001586657

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRAW Stock Option (right to purchase) Award $0 +12,770 $0.000000 12,770 21 Nov 2025 Common Stock 12,770 $2.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest over three years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.